KRAS and malignant colon neoplasm: Because KRAS mutational status could partially determine the biological aspect in colon cancer,52 we compared the mutations detected in plasma and clinicopathological parameters in patients with KRAS mutation‐positive with those in patients with KRAS mutation‐negative.